Showing results (331-340 of 367) with videos related to

Sort By:
Pageof 37
Diabetic Medicine : a Journal of the British Diabetic Association|August 8, 2017
Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypassM S Svane, M B Toft-Nielsen, V B Kristiansen, et al.
Diabetes|March 1, 1993
Differential expression of glutamic acid decarboxylase in rat and human isletsJ S Petersen, S Russel, M O Marshall, et al.
The Journal of Clinical Endocrinology and Metabolism|January 12, 2010
Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesityR Rabøl, S Larsen, P M V Højberg, et al.
Diabetologia|March 23, 2011
Increased mitochondrial substrate sensitivity in skeletal muscle of patients with type 2 diabetesS Larsen, N Stride, M Hey-Mogensen, et al.
International Journal of Obesity (2005)|October 8, 2014
Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight lossE W Iepsen, J Lundgren, C Dirksen, et al.
Diabetologia|April 28, 2012
Mechanisms of improved glycaemic control after Roux-en-Y gastric bypassC Dirksen, N B Jørgensen, K N Bojsen-Møller, et al.
Ugeskrift for Laeger|June 10, 1996
[Clinical consequences of intranasal insulin therapy in insulin-dependent diabetes mellitus]J C Hilsted, S Madsbad, M H Rasmussen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 14, 2011
Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetesA Kaas, C Pfleger, A V Kharagjitsingh, et al.
European Journal of Endocrinology|November 18, 2000
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled studyJ O Jørgensen, A M Rosenfalck, S Fisker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 19, 2008
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitusT Vilsbøll, B Brock, H Perrild, et al.
Pageof 37